The National Institute of Arthritis and Musculoskeletal and Skin Diseases is offering a grant to support Research Project Grant (R01) applications focusing on clinical observational (CO) studies for musculoskeletal, rheumatic, or skin diseases. The grant aims to gather data essential for designing future clinical trials or observational studies, enhance clinical study designs, and develop objective biomarkers or outcome measures. Applicants are encouraged to address key obstacles in clinical project design, such as determining appropriate outcome measures and understanding disease progression. Only observational studies will be funded through this opportunity. Closing date for applications is November 3rd, 2020.
Opportunity ID: 300333
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-18-597 |
Funding Opportunity Title: | Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 29, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | Nov 03, 2020 |
Current Closing Date for Applications: | Nov 03, 2020 |
Archive Date: | Dec 09, 2020 |
Estimated Total Program Funding: | – |
Award Ceiling: | $225,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | For profit organizations other than small businesses Special district governments Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities City or township governments State governments Private institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education County governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) is to encourage Research Project Grant (R01) applications to pursue clinical observational (CO) studies to obtain data necessary for designing clinical studies for musculoskeletal, rheumatic, or skin diseases or conditions. A future clinical study may include a clinical trial or observational study. Research data from observational cohort studies can enhance clinical study design by providing essential information about disease symptoms, stages and timing of disease progression, comorbid conditions, availability of potential research participants, and outcomes that are important to patients. CO studies also can facilitate efforts to develop and/or validate objective biomarkers or subjective outcome measures for use in future clinical studies. Applicants to this FOA are encouraged to propose studies that address significant obstacles or questions in the design of a clinical project, such as determining the appropriate primary or secondary outcome measures, or identifying the stages of disease during which patients are most likely to respond to an intervention. Only observational studies will be supported through this FOA. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-597.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237918 | Jun 02, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259240 | Jun 02, 2018 | Nov 03, 2020 | View |
Package 1
Mandatory forms
300333 RR_SF424_2_0-2.0.pdf
300333 PHS398_CoverPageSupplement_4_0-4.0.pdf
300333 RR_OtherProjectInfo_1_4-1.4.pdf
300333 PerformanceSite_2_0-2.0.pdf
300333 RR_KeyPersonExpanded_2_0-2.0.pdf
300333 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
300333 RR_Budget_1_4-1.4.pdf
300333 RR_SubawardBudget30_1_4-1.4.pdf
300333 PHS398_ModularBudget_1_2-1.2.pdf
300333 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
300333 RR_SF424_2_0-2.0.pdf
300333 PHS398_CoverPageSupplement_5_0-5.0.pdf
300333 RR_OtherProjectInfo_1_4-1.4.pdf
300333 PerformanceSite_2_0-2.0.pdf
300333 RR_KeyPersonExpanded_2_0-2.0.pdf
300333 PHS398_ResearchPlan_4_0-4.0.pdf
300333 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
300333 RR_Budget_1_4-1.4.pdf
300333 RR_SubawardBudget30_1_4-1.4.pdf
300333 PHS398_ModularBudget_1_2-1.2.pdf
300333 PHS_AssignmentRequestForm_3_0-3.0.pdf